Tucker Curran Roberts

This inventor holds 7 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Rqx Pharmaceuticals, Inc., Genentech, Inc., Scripps Research Institute. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tucker Curran Roberts. Retrieved from https://idiyas.com/inventor/tucker-curran-roberts

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 11)

% Patents Active = 57.1

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

6 out of 6

Rqx Pharmaceuticals, Inc.

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2015-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11072635 - Macrocyclic broad spectrum antibiotics (2021-07-27),

2. 10501493 - Broad spectrum antibiotics (2019-12-10),

3. 10392422 - Macrocyclic broad spectrum antibiotics (2019-08-27),

4. 9708368 - Linear peptide antibiotics (2017-07-18),

5. 9309285 - Macrocyclic broad spectrum antibiotics (2016-04-12),

6. 9187524 - Broad spectrum antibiotic arylomycin analogs (2015-11-17),

7. 8999922 - Linear peptide antibiotics (2015-04-07),

Certainly! Here is the article about inventor Tucker Curran Roberts:

Title: Innovator Spotlight: Tucker Curran Roberts - Pioneering Antibiotic Discoveries

Introduction:

Tucker Curran Roberts, a talented inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals with a portfolio of 7 patents under his name.

Latest Patents:

Roberts's latest patents showcase his expertise in developing macrocyclic broad spectrum antibiotics, focusing on compounds that exhibit broad-spectrum bioactivity by targeting bacterial type 1 signal peptidase (SpsB). These compounds offer a novel approach to combating microbial infections and overcoming antibiotic resistance.

Career Highlights:

With a background in pharmaceutical research, Tucker Curran Roberts has worked with reputable companies such as Rqx Pharmaceuticals, Inc. and Genentech, Inc. His innovative approach to drug development has led to breakthroughs in antibiotic treatments, addressing critical needs in the healthcare industry.

Collaborations:

During his tenure at various companies, Roberts collaborated with esteemed professionals, including Peter Andrew Smith and Robert Higuchi. Together, they have propelled research and development efforts, paving the way for groundbreaking discoveries in the field of antibiotics.

Conclusion:

Inventor Tucker Curran Roberts's dedication to innovation and his profound impact on the pharmaceutical landscape are evident through his significant patent portfolio and collaborations with industry experts. His pioneering work in developing broad-spectrum antibiotics has the potential to revolutionize the treatment of microbial infections, offering hope for improved healthcare worldwide.

Profile summary based on public USPTO records.